Diabetes Type 1 Treatment Beyond Insulin: Innovative Approaches

March 20, 2024

Featured image for “Diabetes Type 1 Treatment Beyond Insulin: Innovative Approaches”

Type 1 diabetes is an autoimmune disease where the pancreas stops producing insulin, the hormone needed to regulate blood sugar. Over 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Managing type 1 diabetes is challenging and potentially life-threatening, requiring round-the-clock monitoring and administration of insulin. However, new research is exploring whether we can treat type 1 diabetes without relying solely on injected insulin.

The Critical Role of Insulin in Managing Type 1 Diabetes

Insulin is essential for people with type 1 diabetes to control blood glucose levels and survive. Without enough insulin, glucose builds up in the bloodstream instead of being absorbed by cells for energy. High blood sugar then leads to dangerous short-term complications like diabetic ketoacidosis and long-term issues such as nerve damage, blindness, kidney disease and cardiovascular disease.

That’s why the discovery of insulin in 1921 was a medical miracle, enabling people with type 1 diabetes to regulate their blood sugar with injections and lead healthier lives. Prior treatment options like starvation diets had dismal results. Even today, insulin forms the foundation of type 1 diabetes management.

But the need for frequent blood glucose testing and insulin administration takes a major daily toll. And it doesn’t eliminate the risks of diabetes complications over time. That has sparked major interest in finding alternatives beyond standard insulin therapy.

Artboard 1 14

Currently Available Non-Insulin Treatments

At this time, there is no way for people with type 1 diabetes to survive without taking some form of externally-administered insulin. However, research has uncovered certain non-insulin drugs that can be used alongside insulin injections to improve blood sugar control:

  • Metformin: Typically a treatment for type 2 diabetes, metformin makes the body more sensitive to insulin and causes the liver to release less glucose. Some evidence shows modest HbA1c and weight reductions when combined with insulin in type 1 diabetes.
  • Pramlintide: This synthetic version of the hormone amylin can help control post-meal blood sugar spikes. Using pramlintide with insulin leads to better HbA1c for some type 1 diabetics.
  • Alpha-glucosidase inhibitors: These oral medications slow down the digestion of carbohydrates and modulate glucose absorption. They may reduce insulin needs by up to 18% based on clinical studies.
  • GLP-1 receptor agonists: These stimulate insulin production and suppress glucagon secretion. Adding a GLP-1 drug to insulin therapy can improve blood sugar control and support weight loss for type 1 diabetics.

However, issues like gastrointestinal side effects and the continued need for insulin injections limit the usefulness of current non-insulin options. They act as helpful additions, not replacements, for standard insulin regimens. But the future looks more promising.

Emerging Experimental Therapies to Eliminate Insulin Dependence

Cutting-edge research aims to fulfil the ultimate goal for type 1 diabetes treatmentrestoring the body’s ability to produce its own insulin, eliminating all injections. If successful, these experimental cellular and gene therapies could permanently transform management of the disease.

Pancreatic Islet Transplantation

One exciting approach under study transfers clusters of insulin-producing cells, called islets, from an organ donor pancreas into people with type 1 diabetes. A successful islet transplant can lead to normal glycemic control without insulin therapy.

  • In one Penn Medicine study, all patients achieved excellent blood glucose control for over a year with no insulin required after islet transplantation.

However, there are still barriers to widespread use, including limited donor pancreas availability and side effects of immunosuppressant drugs needed to prevent transplant rejection. But refinements in protocol and improved immunosuppression methods give hope.

Stem Cell-Derived Pancreatic Cells

Rather than rely on donor organs, some researchers are differentiating stem cells into fully functional, insulin-secreting beta cells to replace those lost in type 1 diabetes.

  • In a major milestone, the FDA recently approved this stem cell-based treatment for certain patients with type 1 diabetes.
  • Early testing found over 80% of patients achieved insulin independence for at least 3 months after receiving the stem cell-derived islet cells.

With further tweaks to improve durability, stem cell therapy offers an exciting path to potentially permanent insulin freedom. Cellular reprogramming and 3D bioprinting technologies could also generate unlimited beta cells for transplantation.

Gene Therapy

Rather than replace damaged beta cells, gene therapies aim to protect remaining working cells from autoimmune attack. Some strategies involve knocking out, silencing or editing genes linked to type 1 diabetes development.

Gene therapy holds promise to precisively correct the genes driving type 1 diabetes without more invasive transplantation procedures.

Artboard 1 copy 17

Lifestyle Adjustments are Still Necessary

While future scientific discoveries could eliminate insulin injections for type 1 diabetes, other key lifestyle therapies will remain crucial to minimize complications:

  • Healthy eating: Following a balanced, low-glycemic diet reduces blood sugar variability despite insulin needs.
  • Active lifestyle: Regular exercise helps with blood glucose control and promotes cardiovascular health.
  • Stress reduction: Managing psychological stress can help maintain more consistent blood sugars.
  • Close monitoring: Checking blood glucose levels frequently lets patients properly calibrate insulin dosing.

Making positive lifestyle changes empowers patients to take charge of their health regardless of innovations in pharmaceutical treatment. Diet, activity level, and mental health all profoundly impact diabetes management. An integrative approach addresses biological and behavioral factors influencing outcomes.

The Future of Treating Type 1 Diabetes Without Insulin

While daily insulin injections or pump infusions remain the current reality for type 1 diabetics, innovations in cellular therapy and gene editing bring hope for a future free from externally-administered insulin. Key advantages these experimental techniques offer include:

  • Restoring the body’s ability to modulate insulin secretion automatically
  • Minimizing blood sugar variability and hypoglycemia risk
  • Drastically reducing diabetes management burden
  • Improving quality of life and health outcomes

However, even if such scientific breakthroughs succeed, type 1 diabetes is a complex chronic disease requiring an array of treatment approaches for optimal control. A multilayered management strategy encompassing emerging medical therapies, lifestyle behaviors, patient mindset and access to education and technology support offers the best chance at positive outcomes for people living with type 1 diabetes now and in the years ahead.

Frequently Asked Questions

Can you survive without insulin if you have type 1 diabetes?

No, insulin injections are required for people with type 1 diabetes to stay alive. Without supplemental insulin to regulate blood sugar, they will experience escalating hyperglycemia leading to dangerous, potentially fatal diabetic ketoacidosis. However, researchers are pursuing ways to eliminate external insulin dependence through treatment advances.

What happens if a type 1 diabetic stops taking insulin?

Without insulin administration, blood glucose concentrations climb precipitously due to lack of absorption by cells for metabolism and inadequate glucose output suppression. This leads to short-term effects like excessive thirst and urination, nausea and vomiting. Longer-term, extreme hyperglycemia and ketoacidosis causes coma, brain swelling and organ failure that may ultimately prove fatal.

How close are we to curing type 1 diabetes?

There is great progress toward more minimally invasive and effective therapies that relieve the burden of type 1 diabetes management. Cell-based treatments like islet transplants and stem cell-derived pancreatic beta cells offer potential for insulin independence, while gene editing may protect remaining islet cells from autoimmune destruction. Combining emerging techniques gives hope for driving type 1 diabetes into remission without lifelong insulin injections within the coming one to two decades.

What is the latest research on type 1 diabetes treatments?

Cutting-edge areas researchers are actively exploring for better type 1 diabetes management include encapsulated cell implants, advanced insulin pumps and closed-loop systems, immunotherapy to reinstate immune tolerance, probiotics and microbiome modulation, and therapies targeting the root genetic drivers of islet cell dysfunction and death. Integrating the most promising experimental techniques into standard insulin regimens promises to ease the daily burden for patients.

Could we prevent type 1 diabetes?

While the exact trigger for the abnormal autoimmune response causing type 1 diabetes is still unknown, increased understanding of genetic susceptibility and environmental risk factors shows preventing a subset of cases could be possible with early intervention. Lifestyle changes and microbiome-based therapies are under study for high-risk individuals likely to develop type 1 diabetes to help preserve pancreatic islet cell function before extensive damage occurs.

In Conclusion:

Until regenerative medicine discoveries come to fruition, managing type 1 diabetes requires diligent blood glucose monitoring and insulin replacement. Still, prudent lifestyle choices around diet, activity levels, and stress reduction allow patients to optimize control. Ongoing scientific research offers hope that transformative treatments will one day free people from exogenous insulin dependence. In the meantime, taking ownership over all aspects within patients’ control helps counter the challenges of living with this disease.

Rate this post

Related articles


Cold Plasma System

The world's first handheld cold plasma device

Learn More

Made in USA